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Objective. The aim of this case study was to describe an international case series of polymorphous low-grade
adenocarcinoma (PLGA) affecting the upper lip.
Material and Methods. Over a 30-year-period, the files of five pathology services were reviewed for PLGA affecting the upper
lip. Hematoxylin and eosinestained slides were reviewed by three oral and maxillofacial pathologists, and microscopic
features were described. Clinical data were retrieved from patients’ medical records.
Results. The review identified 11 cases of upper lip PLGAs, with a complete set of clinical data available for 5 cases. There
was a male predominance (1.2:1), and the mean age was 58.7 years. Most cases presented as small asymptomatic swellings
that resembled benign tumors. All patients underwent surgery, and no recurrences or metastases were reported in the 8 cases
from which follow-up data were available. Microscopically, the typical polymorphic architectural arrangement of PLGA was
seen in all cases, with lobular, trabecular, papillary, and cribriform patterns identified. Perineural invasion, normal gland
entrapment, Indian filing, and concentric growth were frequently identified.
Conclusion. PLGA must be included in the list of differential diagnoses of tumors affecting the upper lip because of its similar
clinical presentation to benign entities. The follow-updata available from8of 11 cases suggest that these tumors followa low-grade
clinical course, similar to the majority of palatal cases of PLGA. (Oral Surg Oral Med Oral Pathol Oral Radiol 2015;119:566-571)Salivary gland tumors are an uncommon group of
neoplasms, which account for approximately 3% to
10% of all head and neck tumors.1 Their morphologic
and clinical heterogeneity can result in a wide
differential diagnosis and incorrect diagnoses.
Among salivary gland malignancies, polymorphous
low-grade adenocarcinoma (PLGA) clearly illustrates
such diagnostic difﬁculty. Before its original recognition
as an independent entity in 1983, most cases of PLGA
were included in the spectrum of adenoid cystic carci-
noma (AdCC), and therefore, both entities share
numerous overlapping microscopic features.2-5 In
contrast to AdCC, PLGA is virtually restricted to the
intraoralminor salivary glands, especially from thepalate,
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566The identiﬁcation of PLGA in other intraoral sites is
uncommon, and when such presentation is recognized,
it frequently raises a range of diagnostic possibilities.
Canalicular adenoma and pleomorphic adenoma are, by
far, the most common salivary gland tumors affecting
the upper lip, and both entities can occasionally reveal
histologic similarity to PLGA, which can uncommonly
be found in this location.1,7-10 Therefore, careful clin-
ical and pathologic examination should be performed to
ensure that a malignant salivary gland tumor is not
missed.
Thus, we aim to describe here the clinicopathologic
features of an international case series of PLGA
affecting the upper lip to better characterize this
exceptionally uncommon clinical presentation.
MATERIAL AND METHODS
A retrospective analysis of the archives of ﬁve diag-
nostic oral pathology services, covering a 30-year-
period from 1983 to 2013 (1996 to 2013 for the Bra-
zilian centers), was carried out. The units supplying theStatement of Clinical Relevance
Although polymorphous low-grade adenocarcinoma
(PLGA) is rarely found in the upper lip, by
describing the clinical and pathologic features of this
entity in this multi-institutional series, we highlight
its uncommon clinical presentation, a feature of note
for both clinicians and pathologists.
Table I. Details of the Pathology services presenting
cases to this series, including the incidence of all minor
salivary gland tumors, total PLGAs (all sites), and
salivary gland tumors in the upper lip, accessioned from
1983 to 2013 (Shefﬁeld, Dallas, and Pretoria) and from
1996 to 2013 (Brazil)
Shefﬁeld Dallas Pretoria Brazil*
Total accessioned cases 55,750 145,710 29,603 24,313
Number of minor salivary
tumors
463 728 461 254
Number of PLGAs (total) 72 16 44 23
Number of upper lip minor
gland tumors
120y 77z 16x 43k
Number of upper lip PLGAs 4 1 3 3
PGLA, polymorphous low-grade adenocarcinoma.
*Shorter time presented due to lack of consistent records.
yPleomorphic adenoma (46), basal cell adenoma or canalicular ade-
noma (55), PLGA (4), adenoid cystic carcinoma (9), mucoepidermoid
carcinoma (1), adenocarcinoma (4) and carcinoma ex-pleomorphic
adenoma (1).
zPLGA (1). No further breakdown available.
xAdenoid cystic carcinoma (1), canalicular adenoma (8), pleomorphic
adenoma (4), and PLGA (3).
kPleomorphic adenoma (30), PLGA (3), adenoid cystic carcinoma (2),
carcinoma ex-pleomorphic adenoma (1), canalicular adenoma (5),
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Services, namely, Piracicaba Dental School, UNI-
CAMP (Brazil); Oral and Maxillofacial Surgery and
Traumatology Service, University of São Paulo
(Brazil); School of Clinical Dentistry, University of
Shefﬁeld (UK); School of Dentistry, University of
Pretoria (South Africa); and Texas A&M University
Baylor College of Dentistry, Dallas, Texas (USA).
Databases of all these departments were reviewed for
cases of salivary gland malignancies, and those diag-
nosed as PLGA involving the upper lip were retrieved.
New 4-mm, hematoxylin and eosinestained sections
were reviewed by three oral pathologists to conﬁrm the
original diagnoses, according to the guidelines of the
World Health Organization Classiﬁcation of Salivary
Gland Tumors.11 Demographic data, including gender,
age, ethnicity, symptomatology, duration, size,
treatment, and follow-up, were gathered from pa-
tients’ medical records. During histologic examination,
data regarding microscopic pattern, presence of Indian
ﬁling, concentric growth, perineural invasion, entrap-
ment of normal glands, pattern of invasion, and stromal
features were carefully described.mucoepidermoid carcinoma (1), papillary cystadenoma (1).RESULTS
Following retrieval of retrospective archived material,
12 cases originally diagnosed as PLGA affecting the
upper lip were identiﬁed. After careful histologic review
(KDH, FF, and DB), one case was excluded from the
study, as its appearance was more consistent with low-
grade carcinoma ex-pleomorphic adenoma. Eleven
cases were included for analysis, although a full set of
clinical data was only available for 5 of these cases. The
relative incidence of upper lip PLGA diagnoses in the
context of overall case load and other salivary gland
tumors diagnosed are presented in Table I. Further
detailed data on the incidence of salivary gland tumors
from Shefﬁeld have been previously published.12
Table II summarizes the demographic data obtained
with the ﬁnal sample. The male-to-female ratio was
1.2:1, and the mean age was 58.5 years (median:
56 years, range from 41 to 77 years). Where patient
reported data were available (n ¼ 6), the tumors were
predominantly asymptomatic (n ¼ 5), but in one case,
the patient reported a numb sensation. A mean time of
duration of 20.6 months (range 1-48 months) was re-
ported by patients, and during clinical examination,
lesions presented as submucosal, slow-growing, small
diameter tumors (Figure 1A), although one large
neoplasm was also found (Figure 1B). Surgery was
the therapeutic modality for all patients whose
treatment data were available, and no recurrences or
metastases were described in the 8 cases for which
follow-up data were available.Microscopic features of cases are listed in Table III.
Some tumors were markedly multilocular, particularly
the larger ones. Some had been excised with
overlying oral mucosa, and the tumors have a variable
relationship with this: Some extended very close,
whereas in others, there was a clear zone of
connective tissue separation. No ulceration was noted
in any of these cases. In keeping with the
polymorphous presentation, all described histologic
growth patterns could be found in the cases, with the
lobular subtype being the most frequently
encountered. Focal cribriform or trabecular areas were
identiﬁed in most tumors, and papillary cystic areas
were occasionally noted. The ductal structures in the
trabecular form were single layered, with no apparent
luminal and abluminal components. Presence of
Indian ﬁling (54.5%), perineural invasion (54.5%)
(Figure 1C), concentric growth (36.4%) (Figure 1D),
and entrapment of normal glands (36.4%), all features
often described in cases of PLGA, were also variably
seen in our samples. A collagenous stromal
compartment was the most frequently described, but
no marked stromal desmoplasia was identiﬁed. In
some cases, tumor islands were embedded in a
surrounding myxocollagenous stroma.
Cytologically, the neoplastic cells presented the
typical bland, “washed-out,” round, nuclear appearance,
with scattered nucleoli only occasionally evident. Nu-
clear pleomorphism and mitoses were largely absent,
Table II. Clinical features of PLGA cases affecting the upper lip
Case Country Gender Age Ethnicity Symptomatology
Duration
(Months) Size (cm) Treatment Margins Follow-up
1 USA Male 46 White Asymptomatic 1 0.5  0.4  0.4 Surgery Clear NED: 2 years
2 Brazil Male 70 White Asymptomatic 24 2.0  2.0  0.8 Surgery Clear NED: 8 years
3 Brazil Male 70 White NK 36 0.3  0.3  0.2 Surgery Clear NED: 8 years
4 Brazil Female 41 White Asymptomatic 48 2.0  2.0  1.0 Surgery Clear NED: 6 years
5 South Africa Female 56 White NK 8 1.5  1.0  0.5 Surgery Clear NED: 4 years
6 South Africa Male NK Black Asymptomatic NK 3.0  2.0  2.0 Surgery Involved NED: 3 years
7 South Africa Male 55 Black NK NK 5.0  4.0  3.0 Surgery Involved NK
8 UK Female 51 White Asymptomatic 6 0.7  0.7  0.3 Surgery Fragmented NK
9 UK Male 51 White NK NK 1.2  1.0  0.6 Surgery Clear NED: 5 years
10 UK Female 77 White Numbness 6 2.0  1.1  0.8 Surgery Clear NED: 6 years
11 UK Female 68 White NS 36 1.1  1.0  0.9 Surgery Incisional only NK
PGLA, polymorphous low-grade adenocarcinoma; NK, not known; NED, no evidence of disease; NS, not signiﬁcant.
Fig. 1. Clinical and microscopic features of upper lip polymorphous low-grade adenocarcinoma (PLGA). A, Cases more
commonly presented as a small, normal-colored and nonulcerated nodules resembling benign tumors. This photograph is from
case 3. B, More aggressive appearing lesions were also found. In this case, the tumor exhibited a larger size with an irregular and
telangiectatic surface (case 4). C, Perineural involvement was a frequent microscopic ﬁnding in the sample analyzed (example from
case 4). D, Concentric growth pattern was found in 36.4% of the cases (example from case 4).
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displayed a pushing type of inﬁltration into the sur-
rounding structures; however, some, showed inﬁltration
of small islands of tumor into the adjacent minor sali-
vary gland tissue (e.g., case 1) or fat (e.g., case 5).
Figure 2 (AeH) shows representative photomicrographs
from cases 1, 4, 6, and 9. Virtual microscopy images for
these cases are available as supplementary material.
DISCUSSION
PLGA is an uncommon malignant salivary gland tu-
mor, which exhibits an indolent clinical behavior and
only rarely develops local or distant metastases. It is
virtually always diagnosed in the minor glands of theoral cavity, and the palate is, by far, the most affected
subsite.13 Here, we have described the pathologic and
microscopic features of a number of cases of this
unusual clinical presentation of PLGA, highlighting
the importance of including such an entity in the list
of differentials before and during clinical management
of patients. Although most epidemiologic studies
describe the involvement of other intraoral locations,
PLGA cases involving the upper lip are described
only rarely in these studies. There are less than 20
cases in the published literature presented as
individual case reports and in case series of minor
salivary gland tumors or PLGA generally.8-10,14-19
There are currently only two published cases that
Table III. Microscopic ﬁndings of PLGA cases affecting the upper lip









1* Lobular Pushing pattern with
areas of inﬁltration
Yes Yes Yes Yes Collagenous
2 Lobular/trabecular/
papillary
Inﬁltrative No No Yes Yes Collagenous/hyalinized
3 Trabecular/lobular Pushing pattern and
inﬁltrative areas
No No Yes No Collagenous/hyalinized
4* Lobular/trabecular Pushing pattern and
inﬁltrative areas
Yes Yes No Yes Collagenous
5* Lobular/cribriform Pushing pattern, well-
circumscribed tumor
No No No Yes Mucoid
6 Lobular Pushing pattern with
areas of inﬁltration
Yes Yes No Yes Hyalinized
7 Cribriform/lobular/
papillary
Pushing pattern No Yes No Yes Mucoid/collageneous/
hyalinized
8 Lobular/trabecular Pushing pattern No No No No Hyalinized
9* Cribriform/lobular Pushing pattern Yes No No No Collagenous/hyalinized
10 Trabecular/cribriform Pushing pattern Yes No Yes No Collagenous
11 Lobular/cribriform/
papillary
Pushing pattern Yes No No No Collagenous
Note: High resolution version of the images marked * are available as eSlide: VM00426 (case 1). eSlide: VM00427 (case 4); eSlide: VM00428
(case 5); eSlide: VM00429 (case 9).
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older female, and in one, the lesion recurred.14,15 In the
larger series, data are not presented in sufﬁcient detail
for direct comparison with our cases, but the overall
proportions of PLGAs and frequency of the lesion in
the upper lip are comparable with those seen in the
contributing centers of this series. The clinical data for
some of these cases are, unfortunately, incomplete, as
was also the case in our series (see Table II).
The low-grade behavior of most PLGAs is consistent
with its clinical presentation. As with previous de-
scriptions of PLGA,20 in the current sample, we found
submucosal slow-growing lesions with a steady evolu-
tion, some present for 4 years and most commonly
presenting as small diameter neoplasms, although one
occasional case presented as a large telangiectatic tumor.
El-Naaj et al.6 reported that PLGA cases affecting the lip
tend to present in smaller sizes, possibly due to earlier
recognition by the patient. Despite its hallmark
microscopic feature of neural involvement, pain or
paresthesia is usually not reported by the patients.10
This was exempliﬁed in our series, where numbness
of the affected lip was described by only one patient,
suggesting that the simple histologic presence of a
perineural growth might not be a reliable parameter to
predict a painful clinical presentation of this lesion.
Speight and Barrett (2009)21 reported a similar
observation in AdCC in their study, where only 25%
of the cases demonstrating nerve involvement seemed
to be associated with clinical signs and symptoms. In
contrast, other neurotropic malignancies, such as
pancreatic carcinoma, demonstrate a strong associationbetween perineural invasion and pain.22 We failed to
identify any well-conducted study investigating such
association in the context of PLGA, and considering that
pain and perineural invasion are clinicopathologic fea-
tures frequently evaluated as prognostic determinants,
we believe that a better understanding of their direct
correlation might be of relevance to improve the
knowledge about the clinical and biologic behavior of
PLGA; therefore, further efforts and investigations
along this line are required.
The male predominance observed in our study is in
contrast to the frequently female preponderance
described for PLGA.13,20 However, most of our patients
were diagnosed in the sixth and seventh decades of life,
which was in accordance with the general descriptions
of PLGA.20 Despite pooling cases from four continents,
9 of the 11 patients were white, which limits the possible
variation due to differing ethnicities. All patients with
available treatment data had had surgery to remove the
lesions, with no signs of recurrence nor regional or
distant metastases during the follow-up period,
although these data were not available for all patients.
This conﬁrmed the indolent behavior of this tumor and
that surgery is currently the therapeutic approach of
choice for patients affected by PLGA.13,20 The absence
of metastases of PLGA is an important feature that
distinguishes it from the recently recognized cribriform
adenocarcinoma of the tongue or minor glands,23 which
is characterized by more aggressive behavior and
frequent metastases and recurrences. The dominant
cribriform architecture and nuclear features similar to
papillary thyroid carcinoma described in cribriform
Fig. 2. A and B, Representative photomicrographs of case 1 [showing entrapment of minor salivary gland (A) and a concentric
growth pattern round an entrapped duct (B)]. C and D, Case 4 showing a lobular growth pattern (C) and a focus of perineural
inﬁltration (D). E and F, Case 5, showing inﬁltration into adjacent fat (E) and mixed growth pattern, including cribriform areas and
focal ducts (F). G and H, Case 9 showing cribriform islands of tumor (G) and peripheral “Indian ﬁling” (H). High resolution
version of the images are available as eSlide: VM00426 (case 1). eSlide: VM00427 (case 4); eSlide: VM00428 (case 5); eSlide:
VM00429 (case 9).
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PLGA case series. The recent description of PRKD1
gene mutations in PLGA may further help deﬁne this
entity in cases where diagnostic uncertainty exists.24
It is important that PLGA be included in the dif-
ferential diagnosis of salivary gland tumors of the
upper lip despite their preponderance in the palate.
Special attention to distinguish PLGA from the more
common benign tumors affecting the upper lip,
including pleomorphic adenoma and canalicular ade-
noma, is also warranted, especially in small biopsy
specimens, although in some cases, this may provedifﬁcult. No speciﬁc clinical feature can be found in
PLGA to differentiate it from its benign counterparts,
although the presence of telangiectasia on the surface
of the tumor has previously been suggested as an in-
dicator of malignancy.25 Although PLGA is rarely
found in the upper lip, by describing the clinical and
pathologic features of this multi-institutional series,
we have highlighted this uncommon clinical presen-
tation, a feature of note for both clinicians and pa-
thologists. In our series, none of the tumors for which
we had follow-up data recurred, emphasizing its low-
grade behavior.
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